Download App
B2B Partnerships

Pharmacokinetic data partnerships for digital health platforms, clinics, and research institutions.

Halflife Labs maintains a citation-backed compound database indexing 44 peptides, GLP-1 receptor agonists, and related bioactive compounds. Half-life values, mechanism summaries, and classification data are sourced from FDA prescribing labels and peer-reviewed biomedical literature. API licensing, telehealth integration, research access, and OEM licensing are not publicly documented as active products. Their current availability and scope are unknown until confirmed in writing.

44
compound profiles
16
profiles marked FDA-approved
8
compound categories
Per page
sources and evidence labels
Compound profiles prioritize FDA prescribing labels for approved compounds and published pharmacokinetic studies where available. Investigational compounds are labeled by evidence tier, and each profile carries its own reference set traceable to the cited source.

Partnership programmes

Four structured engagement paths are available, each corresponding to a distinct integration or access use case. All programmes are initiated via a single contact form below — select the topic that best describes your use case.

⬡

Database / Data API Access

The 44 profiles are publicly browsable. Programmatic access and integration formats are unknown until confirmed in writing.

⬡

Telehealth Platform Integration

Potential integration inquiries are evaluated individually. No public API, clinical-decision-support integration, or blanket HIPAA status is currently documented.

⬡

Research Access

Controlled-access dataset licensing for academic institutions, longevity research organisations, and clinical research groups. Includes full compound profiles with citations, suitable for systematic reviews, pharmacokinetic meta-analyses, and protocol development studies.

⬡

Data Licensing

OEM data licensing for pharmaceutical informatics platforms, EHR and EMR systems, clinical decision support vendors, and health data aggregators. Flat-rate and consumption-based billing structures available depending on integration volume and use case.

What the dataset contains

The Halflife Labs compound database is a structured pharmacokinetic reference index. The following data fields are available across all compound profiles:

  • Half-life values — plasma half-life and effective duration, expressed in hours or days, sourced from FDA labels or pharmacokinetic trial data.
  • Mechanism of action — concise receptor target and pathway summaries, written from published literature.
  • Compound classification — 8 categories: metabolic, recovery, growth hormone, TRT, insulin, nootropic, longevity, sexual health.
  • Approval status — FDA-approved (primary source: FDA prescribing label) or research compound (labeled with evidence tier).
  • Administration routes — subcutaneous, intramuscular, oral, intranasal, as applicable.
  • Dosing form and concentration — available formulations, where documented in FDA labels or clinical trial protocols.
  • Source citations — each compound profile includes traceable citations to FDA NDA/BLA numbers or PubMed PMIDs.
Browse the compound database → Data methodology → Clinical case studies →

Who this is for

The Halflife Labs dataset is relevant to organisations building or operating in the following spaces. These are the primary use cases driving current B2B inquiries:

  • Telehealth platforms serving compounding prescribers or GLP-1-focused chronic care programmes who need embedded pharmacokinetic reference content.
  • Compounding pharmacies building patient-facing or clinician-facing digital tools that require compound half-life and mechanism data.
  • EHR and clinical decision support vendors integrating peptide, GLP-1, and hormone therapy data into prescriber workflows.
  • Longevity and precision medicine research groups requiring structured, citation-backed pharmacokinetic datasets for protocol development or systematic review.
  • Health data aggregators and pharmaceutical informatics platforms licensing structured compound data for downstream product embedding.
  • Academic institutions conducting pharmacokinetic meta-analyses or therapeutic protocol research in the GLP-1, peptide, or longevity medicine space.

Start a B2B partnership enquiry

Select the topic that best describes your use case — API access, telehealth integration, research access, or data licensing. A member of the Halflife Labs team will respond within 2 business days.

Frequently asked questions

What pharmacokinetic data is available through the Halflife Labs database?
The database indexes 44 public compound profiles — 16 FDA-approved and 28 investigational — with half-life values, mechanism summaries, classification tags, administration routes, and traceable source citations. FDA prescribing labels are the primary source for approved compounds. Investigational compounds are labeled with their evidence tier. See the full compound database for detail on individual entries.
What integration formats does Halflife Labs support for data delivery?
Integration formats are agreed upon during partner onboarding. Available options include structured flat-file delivery, scheduled data feeds, and programmatic API access. The appropriate format depends on the use case, volume, and licensing tier. Enquire via the form to discuss specific technical requirements.
Is the compound dataset HIPAA-aligned?
The Halflife Labs compound database contains pharmacokinetic reference data only — half-life values, mechanism summaries, and citations drawn from public sources. It does not contain patient records, protected health information, or any individually identifiable data. No HIPAA-covered data is present in the dataset.
How is data licensing structured?
Licensing structures include flat-rate annual agreements and consumption-based billing depending on the integration volume and downstream use case. Research access agreements are structured separately with terms appropriate for academic and non-commercial use. Specific pricing is available upon inquiry.
What compound categories are covered?
The database covers eight compound categories: metabolic (GLP-1 receptor agonists, dual/triple agonists), recovery (BPC-157, TB-500, GHK-Cu, and similar peptides), growth hormone secretagogues (CJC-1295, ipamorelin, GHRP series), TRT (testosterone esters, gonadorelin), insulin (rapid-acting through ultra-long), nootropic (Semax, Selank, DSIP), longevity (Epitalon, NAD+, MOTS-c), and sexual health (PT-141, oxytocin). Browse all 44 compounds →
How does the Halflife Labs dataset differ from general drug databases?
The dataset is specifically focused on the peptide, GLP-1, and longevity compound space — a category underrepresented in general pharmaceutical databases. Coverage includes 28 investigational compounds (BPC-157, CJC-1295, Epitalon, and others) where FDA label data does not exist, sourced from the strongest available evidence tier. This makes the dataset relevant to compounding and precision medicine contexts where general drug databases have limited coverage. See the data methodology for sourcing standards.
Affiliate Program

Earn 15% commission on every referred Halflife Labs subscription.

Halflife Labs is a pharmacokinetic reference tool for clinicians, researchers, and precision health practitioners. The public database indexes 44 peptide, GLP-1 receptor agonist, and longevity-compound profiles with citation-backed half-life values and mechanism data. Affiliates earn a 15% commission on each referred subscription.

15%
Commission per referred subscription Payable on confirmed, non-refunded transactions. Processed monthly.
15%
commission rate
45 days
cookie window
44
compounds in database
iOS
App Store (US)

Halflife Labs operates a 15% affiliate commission structure, payable on referred app subscriptions. The affiliate cookie window is 45 days from the date of the referral click. Commissions are processed monthly for confirmed, non-refunded transactions. The 15% rate applies consistently across all approved affiliates.

— Halflife Labs Affiliate Program Terms

What affiliates promote

The Halflife Labs iOS app is a consumer protocol-tracking and pharmacokinetic-reference tool. The public database includes citations. Clinical use and the identities or number of clinician users are not known.

  • 44-compound pharmacokinetic database — half-life values, mechanisms, administration routes, and FDA/literature citations, accessible directly in the app.
  • 16 FDA-approved compound profiles sourced from FDA prescribing labels; 28 investigational profiles labeled by evidence tier.
  • 8 compound categories: metabolic (GLP-1s), recovery (BPC-157, TB-500), growth hormone (ipamorelin, CJC-1295), TRT (testosterone esters), insulin, nootropic (Semax, Selank), longevity (Epitalon, NAD+), sexual health (PT-141).
  • Audience: the identities, professions, and number of active users are not publicly known.
  • Available on the iOS App Store — US market. App Store reviews and press coverage available on request.
View the compound database → See app features → Data methodology → Download the app →

Who qualifies

The affiliate programme is open to individuals and organisations whose audience includes clinicians, researchers, or health-literate consumers. Applications are reviewed individually. Approval is based on audience relevance and content quality, not follower count.

Compounding pharmacists and pharmacy practice educators
Longevity physicians, integrative medicine practitioners, and functional medicine clinicians
Peptide wellness coaches and precision health practitioners
Health content creators, science communicators, and biomedical educators
Digital health platforms and health-tech media publications
Research institutions and clinical education programmes covering peptide or GLP-1 pharmacology

How the programme works

01

Submit your application

Complete the affiliate inquiry form below. Include your name, email, and a brief description of your platform or audience. No minimum follower count is required.

02

Receive your unique referral link

Approved affiliates receive a unique tracking link within 3–5 business days. The link carries a 45-day cookie window — any subscription purchased within 45 days of a referral click is attributed to your account.

03

Earn 15% on referred subscriptions

For each confirmed, non-refunded subscription purchased through your link, you earn 15% of the subscription value. Commissions are calculated and paid monthly. Affiliate-dashboard tracking availability is unknown until confirmed.

How the 15% rate compares

The Halflife Labs 15% commission is consistent with the established premium tier for longevity health and digital health affiliate programmes. The following market data provides context:

  • The typical commission range for health and wellness digital products is 10–20%, with 15% representing the midpoint of established longevity programmes (source: affiliate programme market benchmarks, 2024).
  • Comparable longevity health affiliate programmes at 15%: Qualia Life / Neurohacker Collective (15% base), ProHealth Longevity (15% at qualifying volume), Onnit (15% via Impact, 45-day cookie).
  • SaaS and digital health apps can credibly offer rates at the upper range of this band because there are no cost-of-goods or shipping costs embedded in the margin structure.
  • The 45-day cookie window exceeds the 30-day industry standard, increasing attribution for educational content where purchase decisions follow a longer consideration cycle.

The Halflife Labs compound database indexes 44 public profiles for peptides, GLP-1 receptor agonists, and related bioactive compounds. Citation-backed half-life values and mechanism summaries are sourced from FDA prescribing labels and published pharmacokinetic literature. The 15% affiliate commission applies to all referred app subscription purchases.

— Halflife Labs, Affiliate Programme Overview

Apply to the affiliate programme

Tell us about your platform and audience. Approved affiliates receive a unique tracking link and access to referral analytics within 3–5 business days.

Frequently asked questions

What is the commission rate?
Halflife Labs pays a 15% commission on each referred subscription purchase. This rate applies to all subscription tiers available in the Halflife Labs iOS app and is consistent across all approved affiliates.
How long is the cookie window?
The affiliate cookie window is 45 days from the date of the referral click. Any subscription purchased within 45 days of a user clicking your affiliate link is attributed to your account and earns the 15% commission.
When are commissions paid?
Commissions are processed monthly for confirmed, non-refunded transactions. A minimum payout threshold applies; amounts below the threshold carry over to the following month.
What can I promote?
Affiliates promote the Halflife Labs iOS app — specifically the compound database and pharmacokinetic reference features. Approved promotional channels include editorial content, newsletters, social media, podcasts, and educational platforms. All promotional content must be factually accurate and must not make health claims beyond what is documented in the app or its supporting literature. See the compound database and methodology page for reference material.
Is there a minimum follower count or traffic threshold?
No minimum follower count or traffic threshold is required. Applications are evaluated based on audience relevance and content quality. A platform reaching 500 engaged clinicians is considered more relevant than a general wellness account with 100,000 followers.
Is the affiliate programme available internationally?
The Halflife Labs app is currently available on the US App Store. Affiliate links can be shared internationally, but commissions are attributable only to purchases completed through the US App Store. Affiliates with US-focused audiences or US-resident followings are most likely to generate attributable conversions.
© 2026 Halflife Labs — halflife-labs.comVienna, Austria